Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Other, SGLT2i Sep 09 | 2021Jardiance Receives Breakthrough Therapy Designation for HFpEF; Metacrine Ph2a NASH Trial Completes Enrollment; Dario Signs Northeast Regional EmployerPurchase Blast
$599
Posted in: Other Sep 08 | 2021Agentix Signs WW Licensing Agreement for T2DM, NAFLD, and Obesity AssetPurchase Blast
$599
Posted in: GLP-1RA, Glucose Monitoring Sep 07 | 2021Oral Sema Ph3 Obesity Program Initiated; GlucoModicum Appoints Former Dexcom Exec; Lilly Contributes to T1DM Camp InitiativePurchase Blast
$599
Posted in: Other Aug 31 | 2021Dario Selected as Digital Behavioral Health Partner for PeopleOne HealthPurchase Blast
$599
Posted in: Dual/triple agonist Aug 30 | 2021Why A Lexicon Deal for Sota Feels Like Momentum Is BuildingPurchase Blast
$599
Posted in: Other Aug 28 | 2021Finerenone Likely to Remain an Add-on to SGLT2i; FIGARO-DKD and FIDELITY Results @ ESC 2021Purchase Blast
$599
Posted in: SGLT2i Aug 27 | 2021EMPEROR-Preserved Creates a Multitude of Complex ImplicationsPurchase Blast$599
Posted in: Other Aug 26 | 2021Novo’s IL-6 Ph3 CVOT Posted to CT.gov; Additional Diamyd T1DM Vaccine AnalysesPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin Aug 26 | 2021Lannett CY Q2 ‘21 (FY Q4 '21) Earnings UpdatePurchase Blast
$599
Posted in: GLP-1RA, Other Aug 25 | 2021Ph3 Icosema Trial Observed; Novel T1DM Treatment Development; DIAGNODE-3 Trial ObservedPurchase Blast
$599
Posted in: Glucagon, Glucose Monitoring, Insulin Delivery Aug 24 | 2021Gvoke Kit Receives FDA Approval; Medtronic Q2 '21 Earnings UpdatePurchase Blast$599
Posted in: Glucagon, Other, SGLT2i Aug 23 | 2021Lexicon and Amarin Present Data at ESC 2021Purchase Blast
$599
Posted in: Other Aug 17 | 2021Does Lifescan’s Expanded Partnership with Cecelia Health Signal a New Business Model to Set Up for an Acquisition by Livongo?Purchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery Aug 16 | 2021Lyumjev Approved for Insulin Pump Use; Dario and Nemaura Q2 '21 Earnings Updates; CHMP Agenda August 16-19Purchase Blast
$599
Posted in: Glucagon, Glucose Monitoring Aug 13 | 2021Xeris Expanded Payor Coverage; Movano Q2 '21 Earnings UpdatePurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, Glucagon, Glucose Monitoring, Other Aug 12 | 2021New Non-invasive CGM Startup Raises $11.7M in Series B; Zealand, Mannkind, and Metacrine Q2 '21 Earnings Updates; Integrity Applications Reverse Stock SplitPurchase Blast
$599
Posted in: Glucose Monitoring, Other Aug 10 | 2021Lifescan and Fitbit Diabetes Collaboration; Sigilon Q2 '21 Earnings UpdatePurchase BlastGet the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.
